1477 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Aghajanian
    Aghajanian
  4. O'Reilly
    O'Reilly
  5. Kris
    Kris
  6. Scher
    Scher
  7. Panageas
    Panageas
  8. Saltz
    Saltz
  9. Schwartz
    Schwartz
  10. Kelsen
    Kelsen

Groups

  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)
  7. Epidemiology and Biostatistics (194)
  8. Biostatistics Service (169)
  9. Gastrointestinal Oncology Service (160)
  10. Population Sciences Research Program (158)
  1. "fatigue"
Formats
  1. Journal Article (1402)
  2. Review (38)
  3. Research Letter (13)
  4. Editorial (10)
  5. Conference Paper (5)
  6. Guidelines (4)
  7. Correspondence (3)
  8. Book Section (2)
Groups
  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)

More Groups

People
  1. Robert Motzer (85)
  2. Clifford Hudis (49)
  3. Carol Aghajanian (46)
  4. Eileen O'Reilly (46)
  5. Howard Scher (44)
  6. Mark Kris (44)

More People

Years
  1. 2025 (60)
  2. 2024 (132)
  3. 2023 (89)
  4. 2022 (46)
  5. 2021 (33)
  6. 2020 (85)

More Years

Publications
  1. Journal of Clinical Oncology (108)
  2. Clinical Cancer Research (82)
  3. Cancer (63)
  4. Lancet Oncology (50)
  5. Gynecologic Oncology (41)
  6. Annals of Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (244)
  2. Springer (133)
  3. American Society of Clinical Oncology (114)
  4. Elsevier Science, Inc. (108)
  5. Oxford University Press (101)
  6. American Association for Cancer Research (89)

More Publishers

Results (1477)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of trastuzumab deruxtecan in HER2-expressing solid tumors by enrollment HER2 IHC status: Post hoc analysis of DESTINY-PanTumor02
    Journal Article

    Oaknin, A.; Lee, J. Y.; Makker, V.; Oh, D. Y.; Banerjee, S.; González-Martín, A.; Jung, K. H.; Ługowska, I.; Manso, L.; Manzano, A.; more...
    Advances in Therapy (2024)

    Fulltext@MSK | Save
  • A biobehavioral perspective on caring for allogeneic hematopoietic stem cell transplant survivors with graft-versus-host disease
    Journal Article

    Lahijani, S.; Rueda-Lara, M.; McAndrew, N.; Nelson, A. M.; Guo, M.; Knight, J. M.; Wiener, L.; Miran, D. M.; Gray, T. F.; Keane, E. P.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2− breast cancer
    Journal Article

    Elias, A. D.; Staley, A. W.; Fornier, M.; Vidal, G. A.; Alami, V.; Sams, S.; Spoelstra, N. S.; Goodspeed, A.; Kabos, P.; Diamond, J. R.; more...
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: A two-arm pilot study evaluating clinical outcomes and immunological correlates
    Journal Article

    Jansen, C. S.; Pagadala, M. S.; Cardenas, M. A.; Prabhu, R. S.; Goyal, S.; Zhou, C.; Chappa, P.; Vo, B. T.; Ye, C.; Hopkins, B.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): Expansion cohorts and correlative analyses
    Journal Article

    Seligson, N. D.; Chen, J. L.; Goodrich, A. C.; Van Tine, B. A.; Campbell, J. D.; Richards, A. L.; Antonescu, C. R.; Liebner, D. A.; Milhem, M. M.; Streicher, H.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Cognitive function in long-term testicular cancer survivors: Impact of modifiable factors
    Journal Article

    Dinh, P. C. Jr; Monahan, P. O.; Fung, C.; Sesso, H. D.; Feldman, D. R.; Vaughn, D. J.; Hamilton, R. J.; Huddart, R.; Martin, N. E.; Kollmannsberger, C.; more...
    JNCI Cancer Spectrum (2024)

    Fulltext@MSK | Save
  • Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies
    Journal Article

    Krystel-Whittemore, M.; Petrova-Drus, K.; Ptashkin, R. N.; Ewalt, M. D.; Yao, J.; Liu, Y.; Zhu, M.; Benhamida, J.; Durham, B.; Kumar, J.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Progression-free survival and safety at 3.5 years of follow-up: Results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer – A plain language summary
    Journal Article

    González-Martín, A.; Pothuri, B.; Vergote, I.; Graybill, W.; Lorusso, D.; McCormick, C. C.; Freyer, G.; Backes, F.; Heitz, F.; Redondo, A.; more...
    Future Oncology (2024)

    Fulltext@MSK | Save
  • CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas
    Journal Article

    Cederquist, G. Y.; Schefflein, J.; Devlin, S. M.; Shah, G. L.; Shouval, R.; Hubbeling, H.; Tringale, K.; Tomas, A. A.; Fregonese, B.; Hajj, C.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: A phase 1 trial
    Journal Article

    Bullock, A. J.; Schlechter, B. L.; Fakih, M. G.; Tsimberidou, A. M.; Grossman, J. E.; Gordon, M. S.; Wilky, B. A.; Pimentel, A.; Mahadevan, D.; Balmanoukian, A. S.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save